rs41270349
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001365999.1(SZT2):c.2550+5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0019 in 1,613,552 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001365999.1 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SZT2 | ENST00000634258.3 | c.2550+5G>A | splice_region_variant, intron_variant | Intron 17 of 71 | 5 | NM_001365999.1 | ENSP00000489255.1 | |||
SZT2 | ENST00000562955.2 | c.2550+5G>A | splice_region_variant, intron_variant | Intron 17 of 70 | 5 | ENSP00000457168.1 | ||||
SZT2 | ENST00000470139.1 | n.1281+5G>A | splice_region_variant, intron_variant | Intron 8 of 17 | 2 | ENSP00000492726.1 |
Frequencies
GnomAD3 genomes AF: 0.00128 AC: 194AN: 152118Hom.: 3 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00304 AC: 764AN: 251346 AF XY: 0.00394 show subpopulations
GnomAD4 exome AF: 0.00196 AC: 2868AN: 1461316Hom.: 27 Cov.: 32 AF XY: 0.00243 AC XY: 1770AN XY: 726970 show subpopulations
GnomAD4 genome AF: 0.00127 AC: 193AN: 152236Hom.: 3 Cov.: 32 AF XY: 0.00158 AC XY: 118AN XY: 74452 show subpopulations
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
Developmental and epileptic encephalopathy, 18 Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
SZT2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at